Evidence map›Paper›PMID 34576140›Full record

ArticleInternational journal of molecular sciences2021

Functional Changes of T-Cell Subsets with Age and CMV Infection.

Fakhri Hassouneh, David Goldeck, Alejandra Pera, Diana van Heemst, P Eline Slagboom, Graham Pawelec, Rafael Solana

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  10. Article
  11. Association of Immune Cell Subsets With Longevity: The Cardiovascular Health Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  12. Article
  13. Article
  14. Expansion of CD57Frontiers in immunology · 2025
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Fakhri HassounehGC01-Immunology and Allergy Group, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Cordoba, Spain.ORCID 0000-0003-1611-7089
David GoldeckDepartment of Internal Medicine II, Centre for Medical Research, University of Tübingen, 72072 Tübingen, Germany.
Alejandra PeraGC01-Immunology and Allergy Group, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Cordoba, Spain.ORCID 0000-0003-1169-8996
Diana van HeemstSection Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Center, 2333 Leiden, The Netherlands.ORCID 0000-0001-8526-7748
P Eline SlagboomMolecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, 2333 Leiden, The Netherlands.
Graham PawelecDepartment of Immunology, University of Tübingen, 72027 Tübingen, Germany.ORCID 0000-0002-3600-0163
Rafael SolanaGC01-Immunology and Allergy Group, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Cordoba, Spain.ORCID 0000-0001-8985-0295
Instituto Maimónides de Investigación Biomédica de Córdoba · ESLeiden University Medical Center · NLHealth Sciences North · CAUniversity of Tübingen · DE

Funding

Consejería de Transformación Económica, Industria, Conocimiento y Universidades. Junta de Andalucía DOC_01421Deutscher Akademischer Austauschdienst 91608878European Commission FP7/2007-2011/259679Instituto de Salud Carlos III PI16/01615Instituto de Salud Carlos III PI19/00075
6 · The paper itself

Abstract

Cytomegalovirus (CMV) latent infection and aging contribute to alterations in the function and phenotype of the T-cell pool. We have demonstrated that CMV-seropositivity is associated with the expansion of polyfunctional CD57+ T-cells in young and middle-aged individuals in response to different stimuli. Here, we expand our results on the effects of age and CMV infection on T-cell functionality in a cohort of healthy middle-aged and older individuals stratified by CMV serostatus. Specifically, we studied the polyfunctional responses (degranulation, IFN-γ and TNF-α production) of CD4+, CD8+, CD8+CD56+ (NKT-like), and CD4-CD8- (DN) T-cells according to CD57 expression in response to Staphylococcal Enterotoxin B (SEB). Our results show that CD57 expression by T-cells is not only a hallmark of CMV infection in young individuals but also at older ages. CD57+ T-cells are more polyfunctional than CD57- T-cells regardless of age. CMV-seronegative individuals have no or a very low percentages of cytotoxic CD4+ T-cells (CD1017a+) and CD4+CD57+ T-cells, supporting the notion that the expansion of these T-cells only occurs in the context of CMV infection. There was a functional shift in T-cells associated with CMV seropositivity, except in the NKT-like subset. Here, we show that the effect of CMV infection and age differ among T-cell subsets and that CMV is the major driving force for the expansion of highly polyfunctional CD57+ T-cells, emphasizing the necessity of considering CMV serology in any study of immunosenescence.

Indexed as

AgedAgingCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCytomegalovirus InfectionsEnterotoxinsFemaleHumansKiller Cells, NaturalMaleMiddle AgedT-Lymphocyte Subsetsenterotoxin B, staphylococcalEnterotoxinsagingCD57cytomegalovirusT-cell response

Identifiers

PMID34576140
PMCPMC8465008
OpenAlexW3201296912

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.